How can I determine a sliding‑scale insulin correction regimen for an adult patient with diabetes?

How to Determine a Sliding Scale Insulin Correction Regimen

Do not use sliding scale insulin alone as the primary insulin regimen for hospitalized patients with type 2 diabetes—instead, use a basal-bolus regimen with correction doses only as supplemental therapy. 1

The Problem with Sliding Scale Insulin Alone

Sliding scale insulin (SSI) as monotherapy is widely condemned in clinical guidelines despite persistent use in hospitals 1. This reactive approach treats hyperglycemia only after it occurs and is associated with:

• Clinically significant hyperglycemia in many patients 1
• Inferior glycemic control compared to physiologic insulin regimens 1
• No evidence supporting its effectiveness after more than 40 years of use 2

The only appropriate use of sliding scale insulin alone is in patients without diabetes who have mild stress hyperglycemia 1. It should never be used as monotherapy in type 1 diabetes 1.

The Recommended Approach: Basal-Bolus with Correction Doses

Initial Dosing Calculation

For insulin-naive patients or those on low doses, calculate the total daily insulin dose (TDD) as 0.3 to 0.5 units/kg body weight 1, 2:

• Lower doses (0.3 units/kg): Use for high-risk patients including those >65 years old, with renal failure, or poor oral intake 1
• Higher doses (0.5 units/kg): Use for younger, healthier patients with good oral intake 1

Distribution of Insulin Doses

Divide the TDD as follows 1, 2:

• 50% as basal insulin: Given once or twice daily (long-acting insulin like glargine or detemir)
• 50% as nutritional insulin: Divided into three equal doses before meals (rapid-acting insulin like lispro, aspart, or glulisine)
• Correction doses: Added to the nutritional doses based on pre-meal glucose values

For Patients Already on Insulin at Home

If the patient is taking ≥0.6 units/kg/day at home, reduce the total daily dose by 20% during hospitalization to prevent hypoglycemia related to poor oral intake 1.

Correction Dose (Sliding Scale) Component

The correction dose is a small fine-tuning adjustment, not the primary therapy 2. Based on recent evidence:

Correction Thresholds

For patients with moderate hyperglycemia on an adequate basal-bolus regimen, use a less aggressive correction threshold 3:

• Standard approach: Correct for blood glucose >260 mg/dL 3
• Intensive approach: Correct for blood glucose >140 mg/dL 3

A 2022 randomized trial demonstrated that among non-ICU patients with type 2 diabetes on optimal basal-bolus therapy, correcting only when glucose exceeded 260 mg/dL (rather than 140 mg/dL) achieved equivalent glycemic control with significantly fewer patients requiring correction doses (34% vs 91%) 3.

Calculating Correction Doses

Use an insulin sensitivity factor (also called correction factor):

• Estimate how much 1 unit of rapid-acting insulin will lower blood glucose
• Common starting point: 1 unit lowers glucose by 30-50 mg/dL (varies by patient weight and insulin sensitivity)
• The correction dose = (current glucose - target glucose) ÷ insulin sensitivity factor 2

Standardization Reduces Errors

Implementing standardized sliding scale protocols with preprinted order forms reduces prescribing errors from 10.3 to 1.2 per 100 patient-days and decreases hyperglycemia episodes from 55.9 to 16.3 per 100 patient-days 4.

Target Glucose Ranges

• General non-ICU patients: 140-180 mg/dL 1
• Critically ill patients: 140-180 mg/dL (targeting 100-140 mg/dL may benefit cardiac surgery patients using computerized algorithms but increases hypoglycemia risk) 1

Common Pitfalls to Avoid

Hypoglycemia risk: The basal-bolus approach carries a 12-30% incidence of mild hypoglycemia in controlled settings 1. Monitor closely and adjust doses accordingly.

Over-treatment of mild hyperglycemia: For patients with blood glucose consistently <200 mg/dL (11.1 mmol/L), consider a basal-plus approach (basal insulin with correction doses only, no scheduled prandial insulin) to reduce hypoglycemia risk 1.

Ignoring nutritional status: Adjust or hold prandial insulin doses if the patient is NPO or has poor oral intake 1. The basal insulin typically continues.

Failure to adjust: Review total daily insulin requirements regularly and adjust the standing doses rather than relying increasingly on correction doses 2.